221 related articles for article (PubMed ID: 6209352)
1. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
3. Western blot analyses of prekallikrein and its activation products in human plasma.
Veloso D; Colman RW
Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
[TBL] [Abstract][Full Text] [Related]
4. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
5. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
6. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
Derkx FH; Bouma BN; Schalekamp MA
J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
[TBL] [Abstract][Full Text] [Related]
7. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
Alving BM; Tankersley DL; Mason BL
J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
[TBL] [Abstract][Full Text] [Related]
8. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
9. Prekallikrein activation in the adult respiratory distress syndrome.
Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
[TBL] [Abstract][Full Text] [Related]
10. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Kallen RJ; Lee SK
Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
[TBL] [Abstract][Full Text] [Related]
11. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
Bury AF; Barrett AJ
Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
[TBL] [Abstract][Full Text] [Related]
12. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
Dors DM; Nuijens JH; Huijbregts CC; Hack CE
Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
[TBL] [Abstract][Full Text] [Related]
13. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
14. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
Soulier JP; Gozin D
Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
[TBL] [Abstract][Full Text] [Related]
15. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
Harpel PC; Lewin MF; Kaplan AP
J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
[TBL] [Abstract][Full Text] [Related]
16. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
Gáti T; Budavári I; Szombath D; Losonczy G
Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
[TBL] [Abstract][Full Text] [Related]
17. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
[TBL] [Abstract][Full Text] [Related]
18. Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media.
Aronen HJ; Kivisaari L; Torstila I; Paavonen T; Meri S; Karonen SL; Standertskjöld-Nordenstam CG
Acta Radiol; 1992 Jul; 33(4):374-8. PubMed ID: 1378750
[TBL] [Abstract][Full Text] [Related]
19. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
[TBL] [Abstract][Full Text] [Related]
20. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
Veloso D; Tseng SY; Craig AR; Colman RW
Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
